AWM
AGN

AE Wealth Management’s Allergan plc AGN Stock Holding History

AE Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,630
Closed -$289K – 1378
2020
Q1 		$289K Sell
1,630
-191
-10% -$36K 0.01% 891
2019
Q4 		$348K Buy
1,821
+165
+10% +$29.8K 0.01% 851
2019
Q3 		$279K Buy
1,656
+129
+8% +$21K 0.01% 816
2019
Q2 		$256K Buy
+1,527
New +$211K 0.01% 809
2018
Q4 		– Sell
-1,135
Closed -$216K – 626
2018
Q3 		$216K Buy
+1,135
New +$209K 0.01% 537

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

AE Wealth Management's AGN Position: Q2 2020 in Review

AE Wealth Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,630 shares — an estimated $289K sold.

AE Wealth Management first reported a position in AGN in Q3 2018 and held it in 5 quarters. The position peaked at $348K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • AE Wealth Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • AE Wealth Management sold 1,630 Allergan plc shares in Q2 2020, an estimated $289K.
  • AE Wealth Management first reported a position in Allergan plc in Q3 2018 and held it in 5 quarters.
  • AE Wealth Management's Allergan plc position peaked at $348K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on AE Wealth Management's 13F filing for Q2 2020, filed 5 Aug 2020.